Tim Vollmer, MD
Professor, Neurology

Photo
Download CV
Medical School:
  • MD, Stanford University School of Medicine (1982)
Undergraduate School:
  • BA, University of Wyoming (WY) (1977)
Internship:
  • Yale-New Haven Medical Center Program (1983)
Residencies:
  • Stanford Hospital and Clinics Program, Chief Resident, Neurology (1987)
  • Stanford Hospital and Clinics Program, Neurology (1985)
Fellowships:
  • Stanford University Program (1986)
Languages: English
Department: Neurology

Professional Titles

  • Vice Chair, Clinical Research
  • Co-Director Rocky Mountain MS Center at Anschutz

Recognition & Awards

  • Physician of Distinction Award, Accelerated Cure Project for Multiple Sclerosis (2011)
  • Best Doctors, Top 1% of neurologists ranked nationally, US News & World Report (2011)
  • • Fellow, American Academy of Neurology 2009, American Academy of Neurology (2009)
  • • University of Colorado Department of Neurology Teaching Award 2009, University of Colorado Residents (2009)

Teaching

  • Professor of Neurology (2008)
    School of Medicine, Neurology
    Neuro-immunology Multiple Sclerosis

Publications

  • Honce JM, Nair KV, Hoyt BD, Seale RA, Sillau S, Engebretson E, Schurr B, Corboy JR, Vollmer TL, Alvarez E. Brain Atrophy Rates for Stable Multiple Sclerosis Patients on Long-Term Fingolimod versus Glatiramer Acetate. Front Neurol. 2020;11:1045. PubMed PMID: 33071934
  • Vollmer TL, Cohen JA, Alvarez E, Nair KV, Boster A, Katz J, Pardo G, Pei J, Raut P, Merchant S, MacLean E, Pradhan A, Moss B. Safety results of administering ocrelizumab per a shorter infusion protocol in patients with primary progressive and relapsing multiple sclerosis. Mult Scler Relat Disord. 2020 Aug 18;46:102454. [Epub ahead of print] PubMed PMID: 33045496
  • Vollmer BL, Nair K, Sillau S, Corboy JR, Vollmer T, Alvarez E. Rituximab versus natalizumab, fingolimod, and dimethyl fumarate in multiple sclerosis treatment. Ann Clin Transl Neurol. 2020 Aug 6. [Epub ahead of print] PubMed PMID: 32767538
  • Engebretson E, Seale RA, Valdez B, Vollmer TL, Medina LD. Validation of the functional assessment of chronic illness therapy - General treatment satisfaction (FACIT-TS-G) in multiple sclerosis. Mult Scler Relat Disord. 2020 Oct;45:102413. PubMed PMID: 32731202
  • Cudkowicz M, Chase MK, Coffey CS, Ecklund DJ, Thornell BJ, Lungu C, Mahoney K, Gutmann L, Shefner JM, Staley KJ, Bosch M, Foster E, Long JD, Bayman EO, Torner J, Yankey J, Peters R, Huff T, Conwit RA, Shinnar S, Patch D, Darras BT, Ellis A, Packer RJ, Marder KS, Chiriboga CA, Henchcliffe C, Moran JA, Nikolov B, Factor SA, Seeley C, Greenberg SM, Amato AA, DeGregorio S, Simuni T, Ward T, Kissel JT, Kolb SJ, Bartlett A, Quinn JF, Keith K, Levine SR, Gilles N, Coyle PK, Lamb J, Wolfe GI, Crumlish A, Mejico L, Iqbal MM, Bowen JD, Tongco C, Nabors LB, Bashir K, Benge M, McDonald CM, Henricson EK, Oskarsson B, Dobkin BH, Canamar C, Glauser TA, Woo D, Molloy A, Clark P, Vollmer TL, Stein AJ, Barohn RJ, Dimachkie MM, Le Pichon JB, Benatar MG, Steele J, Wechsler L, Clemens PR, Amity C, Holloway RG, Annis C, Goldberg MP, Andersen M, Iannaccone ST, Smith AG, Singleton JR, Doudova M, Haley EC, Quigg MS, Lowenhaupt S, Malow BA, Adkins K, Clifford DB, Teshome MA, Connolly N. Seven-Year Experience From the National Institute of Neurological Disorders and Stroke-Supported Network for Excellence in Neuroscience Clinical Trials. JAMA Neurol. 2020 Jun 1;77(6):755-763. PubMed PMID: 32202612
  • Graner M, Pointon T, Manton S, Green M, Dennison K, Davis M, Braiotta G, Craft J, Edwards T, Polonsky B, Fringuello A, Vollmer T, Yu X. Oligoclonal IgG antibodies in multiple sclerosis target patient-specific peptides. PLoS One. 2020;15(2):e0228883. PubMed PMID: 32084151
  • Vollmer B, Ontaneda D, Harris H, Nair K, Bermel RA, Corboy JR, Fox RJ, Vollmer T, Cohen JA, Alvarez E, Hersh CM. Comparative discontinuation, effectiveness, and switching practices of dimethyl fumarate and fingolimod at 36-month follow-up. J Neurol Sci. 2019 Dec 15;407:116498. PubMed PMID: 31644992
  • Wolf AB, Ryerson LZ, Pandey K, McGettigan BM, Vollmer T, Corboy JR, Alvarez E. Rituximab-induced serum sickness in multiple sclerosis patients. Mult Scler Relat Disord. 2019 Nov;36:101402. PubMed PMID: 31542710
  • Vollmer BL, Nair KV, Sillau S, Corboy JR, Vollmer T, Alvarez E. Natalizumab versus fingolimod and dimethyl fumarate in multiple sclerosis treatment. Ann Clin Transl Neurol. 2019 Feb;6(2):252-262. PubMed PMID: 30847358
  • Kletenik I, Alvarez E, Honce JM, Valdez B, Vollmer TL, Medina LD. Subjective cognitive concern in multiple sclerosis is associated with reduced thalamic and cortical gray matter volumes. Mult Scler J Exp Transl Clin. 2019 Jan-Mar;5(1):2055217319827618. PubMed PMID: 30800417
  • Honce JM, Nair KV, Sillau S, Valdez B, Miravalle A, Alvarez E, Schreiner T, Corboy JR, Vollmer TL. Rituximab vs placebo induction prior to glatiramer acetate monotherapy in multiple sclerosis. Neurology. 2019 Feb 12;92(7):e723-e732. PubMed PMID: 30635477
  • Hobart J, Bowen A, Pepper G, Crofts H, Eberhard L, Berger T, Boyko A, Boz C, Butzkueven H, Celius EG, Drulovic J, Flores J, Horáková D, Lebrun-Frénay C, Marrie RA, Overell J, Piehl F, Rasmussen PV, Sá MJ, Sîrbu CA, Skromne E, Torkildsen Ø, van Pesch V, Vollmer T, Zakaria M, Ziemssen T, Giovannoni G. International consensus on quality standards for brain health-focused care in multiple sclerosis. Mult Scler. 2019 Nov;25(13):1809-1818. PubMed PMID: 30381987
  • Hobart J, Bowen A, Pepper G, Crofts H, Eberhard L, Berger T, Boyko A, Boz C, Butzkueven H, Celius EG, Drulovic J, Flores J, Horáková D, Lebrun-Frénay C, Marrie RA, Overell J, Piehl F, Rasmussen PV, Sá MJ, Sîrbu CA, Skromne E, Torkildsen Ø, van Pesch V, Vollmer T, Zakaria M, Ziemssen T, Giovannoni G. International consensus on quality standards for brain health-focused care in multiple sclerosis. Mult Scler. 2018 Nov 1;:1352458518809326. [Epub ahead of print] PubMed PMID: 30381987
  • Vollmer B, Ontaneda D, Bandyopadhyay A, Cohn S, Nair K, Sillau S, Bermel RA, Corboy JR, Fox RJ, Vollmer T, Cohen JA, Alvarez E, Hersh CM. Discontinuation and comparative effectiveness of dimethyl fumarate and fingolimod in 2 centers. Neurol Clin Pract. 2018 Aug;8(4):292-301. PubMed PMID: 30140580
  • Vollmer B, Honce JM, Sillau S, Corboy JR, Vollmer T, Nair K, Alvarez E. The impact of very short transition times on switching from Natalizumab to Fingolimod on imaging and clinical effectiveness outcomes in multiple sclerosis. J Neurol Sci. 2018 Jul 15;390:89-93. PubMed PMID: 29801915
  • Hebert JR, Corboy JR, Vollmer T, Forster JE, Schenkman M. Efficacy of Balance and Eye-Movement Exercises for Persons With Multiple Sclerosis (BEEMS). Neurology. 2018 Feb 27;90(9):e797-e807. PubMed PMID: 29386274
  • Reichardt N, Vollmer M, Holtrop G, Farquharson FM, Wefers D, Bunzel M, Duncan SH, Drew JE, Williams LM, Milligan G, Preston T, Morrison D, Flint HJ, Louis P. Specific substrate-driven changes in human faecal microbiota composition contrast with functional redundancy in short-chain fatty acid production. ISME J. 2017 Dec 1. [Epub ahead of print] PubMed PMID: 29192904
  • Otten C, Brilli M, Vollmer W, Viollier PH, Salje J. Peptidoglycan in Obligate Intracellular Bacteria. Mol Microbiol. 2017 Nov 27. [Epub ahead of print] PubMed PMID: 29178391
  • Spina A, Lenglet A, Beversluis D, de Jong M, Vernier L, Spencer C, Andayi F, Kamau C, Vollmer S, Hogema B, Irwin A, Ngueremi Yary R, Mahamat Ali A, Moussa A, Alfani P, Sang S. A large outbreak of Hepatitis E virus genotype 1 infection in an urban setting in Chad likely linked to household level transmission factors, 2016-2017. PLoS One. 2017;12(11):e0188240. PubMed PMID: 29176816
  • Mejza F, Gnatiuc L, Buist AS, Vollmer WM, Lamprecht B, Obaseki DO, Nastalek P, Nizankowska-Mogilnicka E, Burney PGJ. Prevalence and burden of chronic bronchitis symptoms: results from the BOLD study. Eur Respir J. 2017 Nov;50(5). PubMed PMID: 29167298
  • Hofmann OT, Glowatzki H, Bürker C, Rangger GM, Bröker B, Niederhausen J, Hosokai T, Salzmann I, Blum RP, Rieger R, Vollmer A, Rajput P, Gerlach A, Müllen K, Schreiber F, Zojer E, Koch N, Duhm S. Orientation-Dependent Work-Function Modification Using Substituted Pyrene-Based Acceptors. J Phys Chem C Nanomater Interfaces. 2017 Nov 9;121(44):24657-24668. PubMed PMID: 29152034
  • Kuhnt J, Vollmer S. Antenatal care services and its implications for vital and health outcomes of children: evidence from 193 surveys in 69 low-income and middle-income countries. BMJ Open. 2017 Nov 15;7(11):e017122. PubMed PMID: 29146636
  • Vollmer J, Casares F, Iber D. Growth and size control during development. Open Biol. 2017 Nov;7(11). PubMed PMID: 29142108
  • Robinson JC, Rostami N, Casement J, Vollmer W, Rickard AH, Jakubovics NS. ArcR Modulates Biofilm Formation in the Dental Plaque Colonizer Streptococcus gordonii. Mol Oral Microbiol. 2017 Nov 15. [Epub ahead of print] PubMed PMID: 29139600
  • Vollmer K, Gfroerer S, Theilen TM, Bochennek K, Klingebiel T, Rolle U, Fiegel H. Radical Surgery Improves Survival in Patients with Stage 4 Neuroblastoma. World J Surg. 2017 Nov 10. [Epub ahead of print] PubMed PMID: 29127465
  • Certner RH, Vollmer SV. Inhibiting Bacterial Quorum Sensing Arrests Coral Disease Development and Disease-Associated Microbes. Environ Microbiol. 2017 Nov 10. [Epub ahead of print] PubMed PMID: 29124861
  • Mayer M, Takegami S, Neumeier M, Rink S, Jacobi von Wangelin A, Schulte S, Vollmer M, Griesbeck AG, Duerkop A, Baeumner AJ. Electrochemiluminescence Bioassays can outperform Fluorescence Assays using a New Water-soluble Luminol Derivative. Angew Chem Int Ed Engl. 2017 Nov 9. [Epub ahead of print] PubMed PMID: 29119667
  • Vollmer R, Villagaray R, Cárdenas J, Castro M, Chávez O, Anglin NL, Ellis D. A large-scale viability assessment of the potato cryobank at the International Potato Center (CIP). In Vitro Cell Dev Biol Plant. 2017;53(4):309-317. PubMed PMID: 29104412
  • Fuchs C, Wauschkuhn S, Scheer C, Vollmer M, Meissner K, Kuhn SO, Hahnenkamp K, Morelli A, Gründling M, Rehberg S. Continuing chronic beta-blockade in the acute phase of severe sepsis and septic shock is associated with decreased mortality rates up to 90 days. Br J Anaesth. 2017 Oct 1;119(4):616-625. PubMed PMID: 29121280
  • Ozoh OB, Akanbi MO, Amadi CE, Vollmer W, Bruce N. The prevalence of and factors associated with tobacco smoking behavior among long-distance drivers in Lagos, Nigeria. Afr Health Sci. 2017 Sep;17(3):886-895. PubMed PMID: 29085417
  • Vollmer S, Harttgen K, Kupka R, Subramanian SV. Levels and trends of childhood undernutrition by wealth and education according to a Composite Index of Anthropometric Failure: evidence from 146 Demographic and Health Surveys from 39 countries. BMJ Glob Health. 2017;2(2):e000206. PubMed PMID: 29081994
  • Vollmer B, Nair KV, Sillau SH, Corboy J, Vollmer T, Alvarez E. Comparison of fingolimod and dimethyl fumarate in the treatment of multiple sclerosis: Two-year experience. Mult Scler J Exp Transl Clin. 2017 Jul-Sep;3(3):2055217317725102. PubMed PMID: 28839949
  • Foley JF, Nair KV, Vollmer T, Stephenson JJ, Niecko T, Agarwal SS, Watson C. Long-term natalizumab treatment is associated with sustained improvements in quality of life in patients with multiple sclerosis. Patient Prefer Adherence. 2017;11:1035-1048. PubMed PMID: 28670113
  • Sørensen PS, Comi G, Vollmer TL, Montalban X, Kappos L, Dadon Y, Gorfine T, Margalit M, Sasson N, Rubinchick S, Knappertz V. Laquinimod Safety Profile: Pooled Analyses from the ALLEGRO and BRAVO Trials. Int J MS Care. 2017 Jan-Feb;19(1):16-24. PubMed PMID: 28243182
  • Liu Y, Vollmer T, Havrdova E, Riester K, Lee A, Phillips G, Wang P, Sabatella G. Impact of daclizumab versus interferon beta-1a on patient-reported outcomes in relapsing-remitting multiple sclerosis. Mult Scler Relat Disord. 2017 Jan;11:18-24. PubMed PMID: 28104250
  • Beseler C, Vollmer T, Graner M, Yu X. The complex relationship between oligoclonal bands, lymphocytes in the cerebrospinal fluid, and immunoglobulin G antibodies in multiple sclerosis: Indication of serum contribution. PLoS One. 2017;12(10):e0186842. PubMed PMID: 29059249
View All (36 Total) View Less

Professional Memberships

  • American Academy of Neurology, Member
  • American Association of Immunology, Member
  • American Neurological Association, Member
  • American Society for Experimental NeuroTherapeutics, Member
  • Consortium of Multiple Sclerosis Centers, Member
  • International Society for Neuro Immunology, Member
  • Society for Neuroscience, Member
  • Colorado Society of Clinical Neurologists, Member

Practice Locations

Neurosciences Center - Anschutz
1635 Aurora Ct
4th Floor
Aurora, CO 80045
720-848-2080

UCH - Anschutz Outpatient Pavilion
1635 Aurora Ct
Aurora, CO 80045
720-848-0000

Hospital Affiliation
  • University of Colorado Hospital
  • Children's Hospital Colorado
Center Affiliations

Specialty Information

Specialties
  • Neurology, Board Certification (1991)
  • Neuroimmunology
  • NeuroImmunology Fellowship, Specialized Training (1987)
Conditions & Treatments
  • Brain and Nervous System
  • Immune System - Autoimmune Disorders
  • Immune System
  • Brain and Nervous System - Multiple Sclerosis
Clinical Interests
I am interested in inflammatory diseases of the nervous system, multiple sclerosis, neurosarcoidosis, neuromyelitis optica, Behçet Disease, optic neuritis, transverse myelitis, paraneoplastic syndromes, myasthenia gravis, polymyositis, dermatomyositis, autoimmune encephalitis and acute idiopathic Inflammatory disease of the CNS.

Care Philosophy
My goal is to maximize lifelong brain health by effectively intervening in the inflammatory process leading to CNS injury, encouraging and active healthy lifestyle to maximize neurological reserve and normal aging in late life.

General Information

Medical Schools:
  • MD, Stanford University School of Medicine (1982)
Undergraduate Schools:
  • BA, University of Wyoming (WY) (1977)
Internships:
  • Yale-New Haven Medical Center Program (1983)
Residency Programs:
  • Stanford Hospital and Clinics Program, Chief Resident, Neurology (1987)
  • Stanford Hospital and Clinics Program, Neurology (1985)
Fellowships:
  • Stanford University Program (1986)
Download CV
Languages: English
Department: Neurology
Contact Us
CU Anschutz
Fitzsimons Building

13001 East 17th Place
Campus Box C290
Aurora, CO 80045

Update My Profile
;